These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26014510)

  • 21. Evaluation of inhaler technique, adherence to therapy and their effect on disease control among children with asthma using metered dose or dry powder inhalers.
    Capanoglu M; Dibek Misirlioglu E; Toyran M; Civelek E; Kocabas CN
    J Asthma; 2015 Oct; 52(8):838-45. PubMed ID: 26037396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discontinuation of Inhaled Corticosteroids in COPD and the Risk Reduction of Pneumonia.
    Suissa S; Coulombe J; Ernst P
    Chest; 2015 Nov; 148(5):1177-1183. PubMed ID: 26110239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies.
    Siler TM; Kerwin E; Sousa AR; Donald A; Ali R; Church A
    Respir Med; 2015 Sep; 109(9):1155-63. PubMed ID: 26117292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of inhalation profile and throat geometry on predicted lung deposition of budesonide and formoterol (BF) in COPD: An in-vitro comparison of Spiromax with Turbuhaler.
    Chrystyn H; Safioti G; Keegstra JR; Gopalan G
    Int J Pharm; 2015 Aug; 491(1-2):268-76. PubMed ID: 26043823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aclidinium for Stable COPD.
    Saguil A
    Am Fam Physician; 2015 Jun; 91(11):760. PubMed ID: 26034852
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinically relevant subgroups in COPD and asthma.
    Turner AM; Tamasi L; Schleich F; Hoxha M; Horvath I; Louis R; Barnes N
    Eur Respir Rev; 2015 Jun; 24(136):283-98. PubMed ID: 26028640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of an inhaled corticosteroid/long-acting β2-agonist combination in symptomatic COPD patients in GOLD groups B and D.
    Anzueto A; Jenkins CR; Make BJ; Lindberg M; Calverley PM; Fagerås M; Postma DS; Rennard SI; Tashkin DP
    Eur Respir J; 2015 Jul; 46(1):255-8. PubMed ID: 26022947
    [No Abstract]   [Full Text] [Related]  

  • 28. Safety of Fluticasone Propionate Prescribed for Asthma During Pregnancy: A UK Population-Based Cohort Study.
    Charlton RA; Snowball JM; Nightingale AL; Davis KJ
    J Allergy Clin Immunol Pract; 2015; 3(5):772-9.e3. PubMed ID: 26116951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple inhaler therapy for COPD.
    Lipworth B
    Thorax; 2015 Oct; 70(10):991. PubMed ID: 26092923
    [No Abstract]   [Full Text] [Related]  

  • 30. Control of asthma in real life: still a valuable goal?
    Papaioannou AI; Kostikas K; Zervas E; Kolilekas L; Papiris S; Gaga M
    Eur Respir Rev; 2015 Jun; 24(136):361-9. PubMed ID: 26028647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical asthma phenotyping: A trial for bridging gaps in asthma management.
    Zedan MM; Laimon WN; Osman AM; Zedan MM
    World J Clin Pediatr; 2015 May; 4(2):13-8. PubMed ID: 26015875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler.
    Latorre M; Paggiaro P; Canonica W; Foschino MP; Papi A
    Pulm Pharmacol Ther; 2015 Oct; 34():31-6. PubMed ID: 26278189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease.
    Siddiqui SH; Guasconi A; Vestbo J; Jones P; Agusti A; Paggiaro P; Wedzicha JA; Singh D
    Am J Respir Crit Care Med; 2015 Aug; 192(4):523-5. PubMed ID: 26051430
    [No Abstract]   [Full Text] [Related]  

  • 34. Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol.
    Santus P; Radovanovic D; Paggiaro P; Papi A; Sanduzzi A; Scichilone N; Braido F
    Eur J Intern Med; 2015 Jul; 26(6):379-84. PubMed ID: 26049917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.
    Celli BR; Decramer M; Wedzicha JA; Wilson KC; Agustí AA; Criner GJ; MacNee W; Make BJ; Rennard SI; Stockley RA; Vogelmeier C; Anzueto A; Au DH; Barnes PJ; Burgel PR; Calverley PM; Casanova C; Clini EM; Cooper CB; Coxson HO; Dusser DJ; Fabbri LM; Fahy B; Ferguson GT; Fisher A; Fletcher MJ; Hayot M; Hurst JR; Jones PW; Mahler DA; Maltais F; Mannino DM; Martinez FJ; Miravitlles M; Meek PM; Papi A; Rabe KF; Roche N; Sciurba FC; Sethi S; Siafakas N; Sin DD; Soriano JB; Stoller JK; Tashkin DP; Troosters T; Verleden GM; Verschakelen J; Vestbo J; Walsh JW; Washko GR; Wise RA; Wouters EF; ZuWallack RL;
    Eur Respir Rev; 2015 Jun; 24(136):159-72. PubMed ID: 26028628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indacaterol vs tiotropium in COPD patients classified as GOLD A and B.
    Mahler DA; Kerstjens HA; Donohue JF; Buhl R; Lawrence D; Altman P
    Respir Med; 2015 Aug; 109(8):1031-9. PubMed ID: 26094050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tiotropium and its efficacy in the treatment of COPD.
    Kupczyk M; Szepiel P; Kuna P
    Pneumonol Alergol Pol; 2015; 83(3):229-37. PubMed ID: 26050985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of OM-85 in Patients with Chronic Bronchitis and/or Chronic Obstructive Pulmonary Disease.
    Tang H; Fang Z; Saborío GP; Xiu Q
    Lung; 2015 Aug; 193(4):513-9. PubMed ID: 26044556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.
    Anderson DE; Kew KM; Boyter AC
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging therapeutic options for the treatment of patients with symptomatic asthma.
    McIvor RA
    Ann Allergy Asthma Immunol; 2015 Oct; 115(4):265-271.e5. PubMed ID: 26254973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.